Donaldson Filters Up Q1 Earnings 15% on Strong Sales, Asset Sale
Ticker: DCI · Form: 10-Q · Filed: Dec 4, 2025 · CIK: 29644
Sentiment: bullish
Topics: Filtration, Industrial Manufacturing, Earnings Growth, Share Repurchase, Dividends, Cash Flow, Life Sciences, Global Sales, Capital Allocation
Related Tickers: DCI, FLTR, PNR, XYL
TL;DR
**DCI's Q1 numbers are solid, showing strong earnings growth and smart capital allocation; this stock is a buy for steady returns.**
AI Summary
Donaldson Company, Inc. (DCI) reported a strong financial performance for the three months ended October 31, 2025, with net sales increasing by 3.9% to $935.4 million from $900.1 million in the prior year. Net earnings saw a significant jump of 15.1% to $113.9 million, up from $99.0 million in the same period last year. Diluted earnings per share also rose to $0.97 from $0.81, a 19.8% increase. A notable gain on the sale of fixed assets contributed $9.3 million to operating income, which reached $149.3 million, an increase from $130.8 million. The company's strategic outlook includes evaluating the impact of the One Big Beautiful Bill Act (OBBBA) on its financial statements, with provisions phasing in between fiscal years 2025 and 2027. Cash and cash equivalents increased to $210.7 million from $180.4 million at July 31, 2025, driven by strong operating cash flow of $125.4 million. Share repurchases continued, with 1.2 million shares bought back for $91.9 million during the quarter, reflecting ongoing capital allocation to shareholders.
Why It Matters
Donaldson's robust Q1 performance, marked by a 15.1% net earnings increase and a 3.9% rise in net sales, signals strong operational execution and demand for its filtration solutions. This positive momentum, coupled with increased dividends and share repurchases, should reassure investors about DCI's financial health and commitment to shareholder returns, especially in a competitive industrial market. The strategic investment in Medica and ongoing evaluation of new tax legislation (OBBBA) suggest a forward-looking approach to growth and risk management, potentially enhancing its long-term competitive position against rivals in the filtration and industrial solutions sectors. Employees benefit from a stable, growing company, while customers can expect continued innovation in filtration technology.
Risk Assessment
Risk Level: low — The company exhibits a low risk profile, evidenced by its consistent profitability with net earnings of $113.9 million and strong cash flow from operations of $125.4 million. Furthermore, DCI maintains compliance with all financial covenants on its $600.0 million unsecured revolving credit facility, with $491.6 million available, indicating robust liquidity and financial stability.
Analyst Insight
Investors should consider increasing their position in DCI, given the strong Q1 earnings growth of 15.1% and the company's commitment to shareholder returns through increased dividends and share repurchases. The strategic investment in Medica also points to future growth opportunities in life sciences.
Financial Highlights
- debt To Equity
- 0.44
- revenue
- $935.4M
- operating Margin
- 15.96%
- total Assets
- $3,026.8M
- total Debt
- $674.0M
- net Income
- $113.9M
- eps
- $0.97
- gross Margin
- 35.15%
- cash Position
- $210.7M
- revenue Growth
- +3.9%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Total Net Sales | $935.4M | +3.9% |
Key Numbers
- $935.4M — Net sales (Increased by 3.9% from $900.1M in Q1 2024)
- $113.9M — Net earnings (Increased by 15.1% from $99.0M in Q1 2024)
- $0.97 — Diluted EPS (Increased by 19.8% from $0.81 in Q1 2024)
- $9.3M — Gain on sale of fixed assets (Contributed to operating income in Q1 2025)
- $125.4M — Net cash provided by operating activities (Increased from $72.9M in Q1 2024)
- $91.9M — Treasury stock purchased (1.2 million shares repurchased in Q1 2025)
- $67.9M — Medica investment (Cash consideration for 49% stake in Medica)
- 30.0 cents — Dividends paid per common share (Increased from 27.0 cents in Q1 2024)
- $210.7M — Cash and cash equivalents (As of October 31, 2025, up from $180.4M at July 31, 2025)
- $491.6M — Available on revolving credit facility (As of October 31, 2025, out of a $600.0M facility)
Key Players & Entities
- DONALDSON Company INC (company) — registrant
- Medica S.p.A. (company) — equity method investment
- One Big Beautiful Bill Act (OBBBA) (regulator) — new tax legislation
- U.S. Internal Revenue Service (regulator) — tax authority
- Board of Directors (person) — authorized share repurchases and dividends
- Advanced Filtration Systems Inc. (AFSI) (company) — joint venture partner
- PT Panata Jaya Mandiri (PTPJM) (company) — joint venture partner
FAQ
What were Donaldson Company's net sales for the quarter ended October 31, 2025?
Donaldson Company reported net sales of $935.4 million for the three months ended October 31, 2025, an increase from $900.1 million in the same period of 2024.
How did Donaldson Company's net earnings change in Q1 2025 compared to Q1 2024?
Net earnings for Donaldson Company increased by 15.1% to $113.9 million for the three months ended October 31, 2025, up from $99.0 million in the prior year's quarter.
What was Donaldson Company's diluted EPS for the quarter?
Donaldson Company's diluted net earnings per share were $0.97 for the three months ended October 31, 2025, an increase from $0.81 in the corresponding period of 2024.
What was the impact of the gain on sale of fixed assets for Donaldson Company?
Donaldson Company recognized a gain of $9.3 million on the sale of fixed assets, which contributed to an increase in operating income to $149.3 million for the three months ended October 31, 2025.
How much cash did Donaldson Company generate from operating activities?
Donaldson Company generated $125.4 million in net cash from operating activities for the three months ended October 31, 2025, significantly higher than the $72.9 million generated in the same period last year.
What is the One Big Beautiful Bill Act (OBBBA) and how does it affect Donaldson Company?
The One Big Beautiful Bill Act (OBBBA) is new U.S. tax legislation enacted on July 4, 2025, modifying tax provisions from the 2017 Tax Cuts and Jobs Act. Donaldson Company is currently evaluating the impact of its staggered provisions, effective between fiscal years 2025 and 2027, on its financial statements.
What was Donaldson Company's investment in Medica S.p.A.?
On August 9, 2024, Donaldson Company acquired a 49% non-controlling stake in Medica S.p.A. for approximately $67.9 million, including capitalized transaction costs. Medica specializes in hollow fiber membrane filtration technology.
How many shares did Donaldson Company repurchase in Q1 2025?
During the three months ended October 31, 2025, Donaldson Company repurchased 1.2 million shares of common stock for $91.9 million under its November 2023 stock repurchase plan.
What was the dividend declared by Donaldson Company's Board of Directors?
On November 21, 2025, Donaldson Company's Board of Directors declared a cash dividend of 30.0 cents per common share, payable on December 22, 2025.
Is Donaldson Company in compliance with its debt covenants?
As of October 31, 2025, Donaldson Company was in compliance with all financial and non-financial covenants related to its debt agreements, including interest coverage and leverage ratios.
Risk Factors
- One Big Beautiful Bill Act (OBBBA) Impact [medium — regulatory]: The company is evaluating the financial statement impact of the OBBBA, with provisions phasing in between fiscal years 2025 and 2027. The specific effects on revenue recognition, tax liabilities, and overall profitability are yet to be fully quantified but represent a potential area of change.
- Global Economic Conditions [medium — market]: DCI operates globally, making it susceptible to fluctuations in international economic conditions, currency exchange rates, and geopolitical events. These factors can impact demand for its products and the cost of raw materials.
- Supply Chain Disruptions [medium — operational]: The company relies on a complex global supply chain for raw materials and components. Any disruptions, whether due to natural disasters, trade disputes, or other unforeseen events, could impact production and delivery schedules.
- Interest Rate Fluctuations [low — financial]: Interest expense increased to $7.1 million from $5.5 million in the prior year's quarter, indicating a sensitivity to interest rate changes. Higher rates could increase borrowing costs and impact profitability.
Industry Context
Donaldson Company operates in the highly competitive filtration and separation industry. Key trends include increasing demand for advanced filtration solutions in industrial and healthcare sectors, driven by stricter environmental regulations and a focus on product performance and efficiency. Competitors range from large diversified industrial companies to specialized filtration manufacturers.
Regulatory Implications
The company is monitoring the 'One Big Beautiful Bill Act' (OBBBA), which will phase in provisions between fiscal years 2025 and 2027. The full financial impact of this legislation on revenue recognition and tax liabilities is under evaluation and could lead to adjustments in future reporting.
What Investors Should Do
- Monitor OBBBA impact
- Evaluate operating income drivers
- Appreciate capital allocation strategy
- Observe cash flow generation
Key Dates
- 2025-10-31: End of First Quarter Fiscal Year 2026 — Reporting period for the strong financial results, including increased sales and net earnings.
- 2025-07-31: End of Fiscal Year 2025 — Baseline for comparison of cash and cash equivalents, which increased from $180.4M to $210.7M by October 31, 2025.
- 2025-2027: Phasing of One Big Beautiful Bill Act (OBBBA) Provisions — This period marks the implementation of new regulations that the company is assessing for financial statement impact.
Glossary
- Operating income
- Profitability from a company's core business operations before accounting for interest and taxes. (Increased to $149.3 million, boosted by a $9.3 million gain on the sale of fixed assets, indicating strong core operational performance.)
- Diluted earnings per share (EPS)
- A company's profit divided by the total number of diluted common shares outstanding, including the potential conversion of all dilutive securities. (Rose to $0.97 from $0.81, showing improved profitability on a per-share basis for shareholders.)
- Cash and cash equivalents
- The most liquid assets held by a company, including physical currency, checking account balances, and short-term, highly liquid investments. (Increased to $210.7 million, reflecting healthy cash generation from operations.)
- Treasury stock
- Shares of a company's own stock that it has repurchased from the open market. ($91.9 million was spent on repurchasing 1.2 million shares, demonstrating a commitment to returning capital to shareholders.)
- Comprehensive income
- The total change in a company's equity during a period from non-owner sources, including net income and other comprehensive income (OCI) items like foreign currency translation adjustments. (Total comprehensive income was $121.9 million, higher than net earnings due to positive foreign currency translation and derivative reclassification adjustments.)
- Goodwill
- An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Remained stable at $494.8 million, suggesting no significant acquisitions or impairments during the period.)
Year-Over-Year Comparison
Compared to the prior year's comparable quarter, Donaldson Company reported a 3.9% increase in net sales to $935.4 million and a substantial 15.1% rise in net earnings to $113.9 million. Diluted EPS grew by 19.8% to $0.97. Operating income saw a healthy increase, partly due to a $9.3 million gain on fixed asset sales. Cash flow from operations was notably stronger, increasing from $72.9 million to $125.4 million, bolstering the company's cash position.
Filing Stats: 4,669 words · 19 min read · ~16 pages · Grade level 7.6 · Accepted 2025-12-04 11:57:48
Key Financial Figures
- $5.00 — ange on which registered Common Stock, $5.00 par value DCI New York Stock Exchange
Filing Documents
- dci-20251031.htm (10-Q) — 1011KB
- exhibit31-a20251031.htm (EX-31.A) — 10KB
- exhibit31-b20251031.htm (EX-31.B) — 10KB
- exhibit3220251031.htm (EX-32) — 8KB
- dci-20251031_g1.jpg (GRAPHIC) — 55KB
- dci-20251031_g2.jpg (GRAPHIC) — 55KB
- dci-20251031_g3.jpg (GRAPHIC) — 53KB
- dci-20251031_g4.jpg (GRAPHIC) — 54KB
- 0000029644-25-000147.txt ( ) — 7118KB
- dci-20251031.xsd (EX-101.SCH) — 39KB
- dci-20251031_cal.xml (EX-101.CAL) — 59KB
- dci-20251031_def.xml (EX-101.DEF) — 205KB
- dci-20251031_lab.xml (EX-101.LAB) — 596KB
- dci-20251031_pre.xml (EX-101.PRE) — 422KB
- dci-20251031_htm.xml (XML) — 967KB
FINANCIAL INFORMATION
PART I. FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements DONALDSON COMPANY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (In millions, except per share amounts) (Unaudited) Three Months Ended October 31, 2025 2024 Net sales $ 935.4 $ 900.1 Cost of sales 606.6 580.5 Gross profit 328.8 319.6 Selling, general and administrative 169.6 166.1 Gain on sale of fixed assets ( 9.3 ) — Research and development 19.2 22.7 Operating expenses 179.5 188.8 Operating income 149.3 130.8 Interest expense 7.1 5.5 Other income, net ( 5.3 ) ( 5.2 ) Earnings before income taxes 147.5 130.5 Income taxes 33.6 31.5 Net earnings $ 113.9 $ 99.0 Weighted average shares – basic 115.9 119.9 Weighted average shares – diluted 117.8 121.9 Net earnings per share – basic $ 0.98 $ 0.83 Net earnings per share – diluted $ 0.97 $ 0.81 See Notes to Condensed Consolidated Financial Statements. 2 DONALDSON COMPANY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (In millions) (Unaudited) Three Months Ended October 31, 2025 2024 Net earnings $ 113.9 $ 99.0 Other comprehensive income: Foreign currency translation gain 7.5 4.9 Pension liability adjustment, net of deferred taxes of $ 0.0 and $ 0.0 , respectively 0.5 0.4 Derivatives: (Loss) on hedging derivatives, net of deferred taxes of $ 0.0 and $ 0.3 , respectively ( 0.4 ) ( 1.1 ) Reclassification of hedging derivatives to net earnings, net of taxes of $ 0.0 and $( 0.4 ), respectively 0.4 1.7 Total derivatives — 0.6 Net other comprehensive income 8.0 5.9 Comprehensive income $ 121.9 $ 104.9 See Notes to Condensed Consolidated Financial Statements. 3 DONALDSON COMPANY, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In millions, except share and per share amounts) (Unaudited) October 31, 2025 July 31, 2025 Assets Current assets: Cash and cash equivalents $ 210.7 $ 180.4 Accounts receivable, less allowances of $ 3.5 and $ 2.9 , respectively 655.6 662.2